IL10 and graft versus host disease: While cellular therapy with donor Bregs in humans may be distant, similar features may be present when cord blood is used as the source for haematopoietic stem cells for leukaemia/lymphoma patients; cord blood HSCT induces a robust expansion of IL-10 producing B cells that can suppress CD4+ T cell proliferation in those recipients that escape GvHD [114].